Dr. Reddy’s divests $33M worth of dermatology brands in India
The generic drugmaker Dr. Reddy’s Laboratories will be divesting several of its dermatology brands in return for about $33 million.
According to a release sent to the National Stock Exchange of India on Thursday, the agreement will see Indian pharma company Eris Lifesciences net the trademark for these brands, which Dr. Reddy’s identified as “non-core brands.” Dr. Reddy’s will be picking up Rs 275 crore, or around $33.2 million. The brands had sales last year of around Rs 60 crore, or $7.2 million, according to the release.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.